Drugplain

Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen 75 mg/mL

Octinoxate · LOTION · L'Oreal USA Products Inc

No Recall History
Plain English

Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen is a lotion containing octinoxate at 75 mg/mL, taken topical. Manufactured by L'Oreal USA Products Inc.

Key Facts

Brand Name
Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen
Generic Name
Octinoxate
NDC Code (Product)
49967-007
Manufacturer
L'Oreal USA Products Inc
Strength
75 mg/mL
Dosage Form
LOTION
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
01/01/2010

Recall History

No Recall History

Frequently Asked Questions

What is Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen used for?

Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen contains Octinoxate. It is a lotion taken topical. Consult your doctor for specific uses.

Is Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen a controlled substance?

Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen is not classified as a controlled substance by the DEA.

What is the generic name for Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen?

The generic name for Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen is Octinoxate. There are 12 other brand versions of Octinoxate.

What is the NDC code for Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen 75 mg/mL?

The NDC (National Drug Code) for Maybelline New York Instant Age Rewind Eraser Treatment Makeup Broad Spectrum SPF 18 Sunscreen 75 mg/mL is 49967-007, listed by L'Oreal USA Products Inc.